Filing Details
- Accession Number:
- 0001193805-19-000360
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-04-15 19:38:41
- Reporting Period:
- 2019-04-12
- Accepted Time:
- 2019-04-15 19:38:41
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1661998 | Homology Medicines Inc. | FIXX | () | DE |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1009258 | Deerfield Management Company, L.p. (Series C) | 780 Third Avenue, 37Th Floor New York NY 10017 | Yes | No | Yes | Yes | |
1010823 | L.p. Mgmt Deerfield | 780 Third Avenue 37Th Floor New York NY 10017 | Yes | No | Yes | Yes | |
1301041 | Deerfield Partners, L.p. | 780 Third Avenue 37Th Floor New York NY 10017 | Yes | No | Yes | Yes | |
1352546 | E James Flynn | 780 Third Avenue, 37Th Floor New York NY 10017 | Yes | No | Yes | Yes | |
1603333 | Deerfield Private Design Fund Iii, L.p. | 780 Third Avenue, 37Th Floor New York NY 10017 | Yes | No | Yes | Yes | |
1610540 | Deerfield Mgmt Iii, L.p. | 780 Third Avenue, 37Th Floor New York NY 10017 | Yes | No | Yes | Yes | |
1646981 | Deerfield Healthcare Innovations Fund, L.p. | 780 Third Avenue 37Th Floor New York NY 10017 | Yes | No | Yes | Yes | |
1665736 | Deerfield Mgmt Hif, L.p. | 780 Third Avenue 37Th Floor New York NY 10017 | Yes | No | Yes | Yes |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-04-12 | 533,333 | $22.50 | 1,158,333 | No | 4 | P | Indirect | Through Deerfield Partners, L.P. |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | Through Deerfield Partners, L.P. |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1,988,518 | Indirect | Through Deerfield Healthcare Innovations Fund, L.P. |
Common Stock | 2,613,517 | Indirect | Through Deerfield Private Design Fund III, L.P. |
Footnotes
- This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the "Reporting Persons"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. ("Fund III"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. ("Deerfield Partners"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the "Funds"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P.
- In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.